Advertisement

Osteoporosis International

, Volume 26, Issue 11, pp 2579–2585 | Cite as

Two-year adherence to treatment and associated factors in a fracture liaison service in Spain

  • A. Naranjo
  • S. Ojeda-Bruno
  • A. Bilbao-Cantarero
  • J. C. Quevedo-Abeledo
  • B. V. Diaz-González
  • C. Rodríguez-Lozano
Original Article

Abstract

Summary

A fracture liaison service in Spain is able to maintain 73 % of the patients on antiresorptive 2 years after the fracture.

Introduction

The purpose of this study was to evaluate the 2-year effectiveness of a program for the secondary prevention of fractures.

Methods

Fragility fractures in patients over 50 attending the emergency room in our centre are captured by the recruitment system of a secondary prevention program. The unit is attended by a nurse, coordinated by two rheumatologists and with the collaboration of primary care consisted of a training program and annual meetings. The outcome of the program was analysed 2 years after implementation, including: (1) percentage of attendees/eligible; (2) percentage of attendees who start treatment with antiresorptive; (3) percentage of patients who retain treatment after 6, 12, 18 and 24 months; and (4) factors associated to adherence.

Results

After 2 years of implementation, the program detected 1674 patients with fracture, of whom 759 finally entered the program (57 % of eligible). After 3 months, 82 % of patients prescribed an antiresorptive started treatment. After a year, 52 % of the patients in the program, 72 % of those of a prescribed treatment, were taking antiresorptives. Adherence at 24 months among those who had prescribed anti-fracture drugs was 73 %. Factors associated with adherence at 12 months were female sex (76 vs 45 %; p = 0.01) and previous treatment with antiresorptive (86 vs 68 %; p = 0.02).

Conclusions

In Spain, a program designed to prevent secondary fragility fractures based on the collaboration between primary care and rheumatology seems effective in terms of recruitment of patients and adherence to treatment in the mid/long-term.

Keywords

Adherence Bisphosphonates Fracture liaison service Fragility fracture Osteoporosis Secondary prevention Training program 

Notes

Acknowledgments

Authors give thanks to Carmen Alonso, Fabiola Santana, and Ruben Lopez (Rheumatology), Sinforiano Rodriguez (Geriatry), and Manuel de la Torre (Orthopaedics), Hospital Universitario de Gran Canaria Dr. Negrin, for their collaboration and to Loreto Carmona for revising the manuscript.

Conflicts of interest

None.

Funding

Proyecto nacional del Ministerio de Ciencia e Innovación. Instituto de Salud Carlos III: PI11/01429

References

  1. 1.
    Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8Google Scholar
  2. 2.
    Becker DJ, Kilgore ML, Morrisey MA (2010) The societal burden of osteoporosis. Curr Rheumatol Rep 12:186–191CrossRefPubMedGoogle Scholar
  3. 3.
    Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3–S7CrossRefPubMedGoogle Scholar
  4. 4.
    Nikitovic M, Wodchis WP, Krahn MD, Cadarette SM (2013) Direct health-care costs attributed to hip fractures among seniors: a matched cohort study. Osteoporos Int 24:659–669PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRefPubMedGoogle Scholar
  6. 6.
    Mitchell PJ, Chem C (2013) Secondary prevention and estimation of fracture risk. Best Pract Res Clin Rheumatol 27:789–803CrossRefPubMedGoogle Scholar
  7. 7.
    George GH, Patel S (2000) Secondary prevention of hip fracture. Rheumatology (Oxford) 39:346–349CrossRefGoogle Scholar
  8. 8.
    Mueller D, Gandjour A (2011) Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis. Appl Health Econ Health Policy 9:259–273CrossRefPubMedGoogle Scholar
  9. 9.
    Sale JE, Beaton D, Bogoch E (2014) Secondary prevention after an osteoporosis-related fracture: an overview. Clin Geriatr Med 30:317–332CrossRefPubMedGoogle Scholar
  10. 10.
    Prasad N, Sunderamoorthy D, Martin J, Murray JM (2006) Secondary prevention of fragility fractures: are we following the guidelines? Closing the audit loop. Ann R Coll Surg Engl 88:470–474PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Kamel HK (2005) Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough? J Clin Rheumatol 11:68–71CrossRefPubMedGoogle Scholar
  12. 12.
    Drew S, Sheard S, Chana J, Cooper C, Javaid MK, Judge A, REFReSH study group (2014) Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England. Osteoporos Int 25:2427–2433PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Chakravarthy J, Ali A, Iyengar S, Porter K (2008) Secondary prevention of fragility fractures by orthopaedic teams in the UK: a national survey. Int J Clin Pract 62:382–387CrossRefPubMedGoogle Scholar
  14. 14.
    Sheehan J, Mohamed F, Reilly M, Perry IJ (2000) Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice. Ir Med J 93:105–107PubMedGoogle Scholar
  15. 15.
    Trevisan C (2011) Secondary prevention of fractures and compliance to treatment in osteoporosis. Aging Clin Exp Res 23(2 Suppl):22–24PubMedGoogle Scholar
  16. 16.
    Berry SD, Misra D, Hannan MT, Kiel DP (2010) Low acceptance of treatment in the elderly for the secondary prevention of osteoporotic fracture in the acute rehabilitation setting. Aging Clin Exp Res 22:231–237PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Chandran M, Tan MZ, Cheen M, Tan SB, Leong M, Lau TC (2013) Secondary prevention of osteoporotic fractures—an “OPTIMAL” model of care from Singapore. Osteoporos Int 24:2809–2817CrossRefPubMedGoogle Scholar
  18. 18.
    Dehamchia-Rehailia N, Ursu D, Henry-Desailly I, Fardellone P, Paccou J (2014) Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital’s fracture liaison service between January 2010 and December 2011. Osteoporos Int 25:2409–2416CrossRefPubMedGoogle Scholar
  19. 19.
    Ganda K, Puech M, Chen JS et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393–406CrossRefPubMedGoogle Scholar
  20. 20.
    Herrera A, Carpintero P, Fernandez-Perez C, Hernandez-Vaquero D, Martinez AA, Suso S (2011) Secondary prevention in osteoporotic fractures. The GIOS project. Med Clin (Barc) 136:50–55CrossRefGoogle Scholar
  21. 21.
    Ojeda-Bruno S, Naranjo A, Francisco-Hernández F, Erausquin C, Rúa-Figueroa I, Quevedo JC et al (2011) Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates. Osteoporos Int 22:1821–1828CrossRefPubMedGoogle Scholar
  22. 22.
    Naranjo A, Ojeda-Bruno S, Bilbao Cantarero A, Quevedo Abeledo JC, Henriquez-Hernandez LA, Rodriguez-Lozano C (2014) Results of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians. Reumatol Clin 10:299–303CrossRefPubMedGoogle Scholar
  23. 23.
    Hjalmarson HV, Ahgren B, Kjolsrud MS (2013) Developing interprofessional collaboration: a longitudinal case of secondary prevention for patients with osteoporosis. J Interprof Care 27:161–170CrossRefPubMedGoogle Scholar
  24. 24.
    Meadows LM, Mrkonjic LA, O’Brien MD, Tink W (2007) The importance of communication in secondary fragility fracture treatment and prevention. Osteoporos Int 18:159–166CrossRefPubMedGoogle Scholar
  25. 25.
    Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051–2065CrossRefPubMedGoogle Scholar
  26. 26.
    Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141CrossRefPubMedGoogle Scholar
  27. 27.
    National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. In: National Osteoporosis Foundation, ed. Washington, DC; 2010.Google Scholar
  28. 28.
    Sale JE, Beaton D, Posen J, Bogoch E (2013) Medication initiation rates are not directly comparable across secondary fracture prevention programs: reporting standards based on a systematic review. J Clin Epidemiol 66:379–385CrossRefPubMedGoogle Scholar
  29. 29.
    Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Boudou L, Gerbay B, Chopin F, Ollagnier E, Collet P, Thomas T (2011) Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int 22:2099–2106CrossRefPubMedGoogle Scholar
  31. 31.
    Eekman DA, van Helden SH, Huisman AM, Verhaar HJ, Bultink IE, Geusens PP et al (2014) Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporos Int 25:701–709CrossRefPubMedGoogle Scholar
  32. 32.
    Ganda K, Schaffer A, Pearson S, Seibel MJ (2014) Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int 25:1345–1355CrossRefPubMedGoogle Scholar
  33. 33.
    Reynolds K, Muntner P, Cheetham TC, Harrison TN, Morisky DE, Silverman S et al (2013) Primary non-adherence to bisphosphonates in an integrated healthcare setting. Osteoporos Int 24:2509–2517CrossRefPubMedGoogle Scholar
  34. 34.
    Lih A, Nandapalan H, Kim M, Yap C, Lee P, Ganda K et al (2011) Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int 22:849–858CrossRefPubMedGoogle Scholar
  35. 35.
    Astrand J, Nilsson J, Thorngren KG (2012) Screening for osteoporosis reduced new fracture incidence by almost half: a 6-year follow-up of 592 fracture patients from an osteoporosis screening program. Acta Orthop 83:661–665PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B et al (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96, e29CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2015

Authors and Affiliations

  1. 1.Department of Rheumatology, Hospital Universitario de Gran Canaria Dr. NegrínUniversidad de Las Palmas de Gran CanariaLas Palmas de Gran CanariaSpain
  2. 2.Medical and Surgical Sciences DepartmentUniversidad de Las Palmas de Gran CanariaLas Palmas de Gran CanariaSpain
  3. 3.Primary Care Service, Gerencia de Atención Primaria de Gran CanariaLas Palmas de Gran CanariaSpain

Personalised recommendations